Recombinant human decorin suppresses liver HepG2 carcinoma cells by p21 upregulation

OncoTargets and Therapy

Volumn 5, Issue , 2012, Pages 143-152

  Zhang, Yucheng ^a   Wang, Yali ^a   Du, Zhenwu ^a   Wang, Qian ^a   Wu, Mei ^a   Wang, Xiaofeng ^a   Wang, Lingling ^a   Cao, Linlin ^a   Hamid, Abdu Selim ^a   Zhang, Guizhen ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Decorin; HepG2; Liver cancer; P21WAF1 CIP1; PcDNA3.1

Indexed keywords

DECORIN; PROTEIN P21;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL STRAIN HEPG2; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84873918208     PISSN: 11786930     EISSN: None     Source Type: Journal    
DOI: 10.2147/OTT.S32918     Document Type: Article

References (28)

1. Yang JD, Roberts LR. Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol. 2010;7(8):448-458.
2. Tralhao JG, Schaefer L, Micegova M, et al. In vivo selective and distant killing of cancer cells using adenovirus-mediated decorin gene transfer. FASEB J. 2003;17(3):464-466.
3. Iozzo RV, Chakrani F, Perrotti D, et al. Cooperative action of germ-line mutations in decorin and p53 accelerates lymphoma tumorigenesis. Proc Natl Acad Sci U S A. 1999;96(6):3092-3097.
4. Bi X, Tong C, Dockendorff A, et al. Genetic deficiency of decorin causes intestinal tumor formation through disruption of intestinal cell maturation. Carcinogenesis. 2008;29(7):1435-1440.
5. Reed CC, Gauldie J, Iozzo RV. Suppression of tumorigenicity by adenovirus-mediated gene transfer of decorin. Oncogene. 2002;21(23): 3688-3695.
6. Reed CC, Waterhouse A, Kirby S, et al. Decorin prevents metastatic spreading of breast cancer. Oncogene. 2005;24(6):1104-1110.
7. Santra M, Skorski T, Calabretta B, Lattime EC, Iozzo RV. Denovo decorin gene expression suppresses the malignant phenotype in human colon cancer cells. Proc Natl Acad Sci U S A. 1995;92(15): 7016-7020.
8. Santra M, Mann DM, Mercer E W, Skorski T, Calabretta B, Iozzo RV. Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases. J Clin Invest. 1997;100(1):149-157.
9. Moscatello DK, Santra M, Mann DM, McQuillan DJ, Wong AJ, Iozzo RV. Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor. J Clin Invest. 1998;101(2):406-412.
10. Santra M, Eichstetter I, Iozzo RV. An anti-oncogenic role for decorin. Down-regulation of ErbB2 leads to growth suppression and cytodifferentiation of mammary carcinoma cells. J Biol Chem. 2000;275(45): 35153-35161.
11. De Luca A, Santra M, Baldi A, Giordano A, Iozzo RV. Decorin-induced growth suppression is associated with up-regulation of p21, an inhibitor of cyclin-dependent kinases. J Biol Chem. 1996;271(31): 18961-18965.
12. Buraschi S, Pal N, Tyler-Rubinstein N, Owens RT, Neill T, Iozzo RV. Decorin antagonizes Met receptor activity and down-regulates {beta}- catenin and Myc levels. J Biol Chem. 2010;285(53):42075-42085.
13. Iozzo RV, Buraschi S, Genua M, et al. Decorin antagonizes IGF receptor I (IGF-IR) function by interfering with IGF-IR activity and attenuating downstream signaling. J Biol Chem. 2011;286(40):34712-34721.
14. Miyasaka Y, Enomoto N, Nagayama K, et al. Analysis of differentially expressed genes in human hepatocellular carcinoma using suppression subtractive hybridization. Br J Cancer. 2001;85(2):228-234.
15. Chung EJ, Sung YK, Farooq M, et al. Gene expression profile analysis in human hepatocellular carcinoma by cDNA microarray. Mol Cell. 2002;14(3):382-387.
16. Krusius T, Ruoslahti E. Primary structure of an extracellular matrix proteoglycan core protein deduced from cloned cDNA. Proc Natl Acad Sci U S A. 1986;83(20):7683-7687.
17. McDoniels-Silvers AL, Nimri C F, Stoner GD, Lubet RA, You M. Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas. Clin Cancer Res. 2002;8(4):1127-1138.
18. Shridhar V, Lee J, Pandita A, et al. Genetic analysis of early-versus late-stage ovarian tumors. Cancer Res. 2001;61(15):5895-5904.
19. Troup S, Njue C, Kliewer E V, et al. Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. Clin Cancer Res. 2003;9(1):207-214.
20. Iozzo RV. The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. Crit Rev Biochem Mol Biol. 1997;32(2):141-174.
21. Goldoni S, Iozzo RV. Tumor microenvironment: modulation by decorin and related molecules harboring leucine-rich tandem motifs. Int J Cancer. 2008;123(11):2473-2479.
22. Zhu JX, Goldoni S, Bix G, et al. Decorin evokes protracted internalization and degradation of the epidermal growth factor receptor via caveolar endocytosis. J Biol Chem. 2005;280(37):32468-32479.
23. Csordas G, Santra M, Reed CC, et al. Sustained down-regulation of the epidermal growth factor receptor by decorin. A mechanism for controlling tumor growth in vivo. J Biol Chem. 2000;275(42):32879-32887.
24. Seidler DG, Goldoni S, Agnew C, et al. Decorin protein core inhibits in vivo cancer growth and metabolism by hindering epidermal growth factor receptor function and triggering apoptosis via caspase-3 activation. J Biol Chem. 2006;281(36):26408-26418.
25. Hill R, Madureira PA, Waisman DM, Lee PW. DNA-PKCS binding to p53 on the p21 WAF1/CIP1 promoter blocks transcription resulting in cell death. Oncotarget. 2011;2(12):1094-1108.
26. Schonherr E, Levkau B, Schaefer L, Kresse H, Walsh K. Decorin-mediated signal transduction in endothelial cells. Involvement of Akt/protein kinase B in up-regulation of p21(WAF1/CIP1) but not p27(KIP1). J Biol Chem. 2001;276(44):40687-40692.
27. Stander M, Naumann U, Wick W, Weller M. Transforming growth factor-beta and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth. Cell Tissue Res. 1999;296(2): 221-227.
28. Grant DS, Yenisey C, Rose RW, Tootell M, Santra M, Iozzo RV. Decorin suppresses tumor cell-mediated angiogenesis. Oncogene. 2002; 21(31):4765-4777.